|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/69 | |
| A61K 9/08 | |||
| A61K 31/568 | |||
| A61K 31/57 | |||
| A61P 15/08 | |||
| A61P 5/34 |
| (11) | Patento numeris | 2925369 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13811121.6 |
| Europos patento paraiškos padavimo data | 2013-11-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-10-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-01-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/003538 |
| Data | 2013-11-22 |
| (87) | Numeris | WO 2014/082724 |
| Data | 2014-06-05 |
| (30) | Numeris | Data | Šalis |
| MI20122027 | 2012-11-28 | IT |
| (72) |
BERNAREGGI, Alberto, CH
PUPPINI, Nadia, CH
NENCIONI, Alessandro, CH
|
| (73) |
Altergon S.A.,
Via Dogana Vecchia 2, 6900 Lugano,
CH
|
| (54) | AQUEOUS ORAL SOLUTIONS OF STEROID HORMONES AND HYDROXYPROPYL-BETA-CYCLODEXTRIN WITH OPTIMISED BIOAVAILABILITY |
| AQUEOUS ORAL SOLUTIONS OF STEROID HORMONES AND HYDROXYPROPYL-BETA-CYCLODEXTRIN WITH OPTIMISED BIOAVAILABILITY |